日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

REASSURE 研究的临床结果和治疗模式:一项关于镭-223治疗转移性去势抵抗性前列腺癌的真实世界观察性研究的计划中期分析

Higano, Celestia S; George, Daniel J; Shore, Neal D; Sartor, Oliver; Miller, Kurt; Conti, Peter S; Sternberg, Cora N; Saad, Fred; Sade, Juan Pablo; Bellmunt, Joaquim; Smith, Matthew R; Chandrawansa, Kumari; Sandström, Per; Verholen, Frank; Tombal, Bertrand

Trends in Recently Emerged Leishmania donovani Induced Cutaneous Leishmaniasis, Sri Lanka, for the First 13 Years

斯里兰卡前13年新出现的杜氏利什曼原虫引起的皮肤利什曼病趋势

Siriwardana, Yamuna; Zhou, Guofa; Deepachandi, Bhagya; Akarawita, Janaka; Wickremarathne, Chandanie; Warnasuriya, Wipula; Udagedara, Chandanie; Ranawaka, Ranthilaka R; Kahawita, Indira; Ariyawansa, Dananja; Sirimanna, Ganga; Chandrawansa, P H; Karunaweera, Nadira D

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

利用汇总患者数据,对两项二线雷莫芦单抗III期研究(REGARD和RAINBOW)中胃癌患者的总生存期进行预后因素分析

Fuchs, Charles S; Muro, Kei; Tomasek, Jiri; Van Cutsem, Eric; Cho, Jae Yong; Oh, Sang-Cheul; Safran, Howard; Bodoky, György; Chau, Ian; Shimada, Yasuhiro; Al-Batran, Salah-Eddin; Passalacqua, Rodolfo; Ohtsu, Atsushi; Emig, Michael; Ferry, David; Chandrawansa, Kumari; Hsu, Yanzhi; Sashegyi, Andreas; Liepa, Astra M; Wilke, Hansjochen

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma

RAINBOW III期研究评估了雷莫芦单抗联合紫杉醇与安慰剂联合紫杉醇治疗既往接受过治疗的胃癌或胃食管交界处腺癌患者的生活质量和体能状态。

Al-Batran, S-E; Van Cutsem, E; Oh, S C; Bodoky, G; Shimada, Y; Hironaka, S; Sugimoto, N; Lipatov, O N; Kim, T-Y; Cunningham, D; Rougier, P; Muro, K; Liepa, A M; Chandrawansa, K; Emig, M; Ohtsu, A; Wilke, H

Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka

在斯里兰卡使用临床工具筛查和诊断皮肤利什曼病

Siriwardana, H V Y D; Senarath, U; Chandrawansa, P H; Karunaweera, N D

Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer

一项随机、II期研究,旨在评估胰岛素样生长因子-1受体抑制剂IMC-A12联合或不联合西妥昔单抗治疗对西妥昔单抗或帕尼单抗耐药的转移性结直肠癌患者的疗效。

Reidy, Diane Lauren; Vakiani, Efsevia; Fakih, Marwan G; Saif, Muhammad Wasif; Hecht, Joel Randolph; Goodman-Davis, Noah; Hollywood, Ellen; Shia, Jinru; Schwartz, Jonathan; Chandrawansa, Kumari; Dontabhaktuni, Aruna; Youssoufian, Hagop; Solit, David B; Saltz, Leonard B